---
$id: https://graph.org.ai/products/commodity/51111774
$type: Product
source: UNSPSC
code: "51111774"
title: "Vorinostat"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vorinostat

**UNSPSC Code**: 51111774
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histone deacetylase inhibitor with the molecular formula C14H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58IFB293JI, chemically known as saha, suberoylanilide hydroxamic acid but generally known as vorinostat, which bears US NIH Compound Identifier 5311. European Medicines Agency schedules Vorinostat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23356. The term VORINOSTAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, No. 3, 2006, List 56). World Health Organization schedules vorinostat in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule vorinostat under HS 29280090 and SITC 51486. As of Q4 2014, VORINOSTAT remains the US FDA Preferred Term for this commodity. Vorinostat bears US NLM identifiers UMLS ID C0672708 and NCI Concept Code C1796. SMILES: O=C(NC1CCCCC1)CCCCCCC(=O)NO.

